Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
SUMMARY Humans exhibit remarkable inter-individual variations in the concentration of small molecules found throughout the body, due in part to concurrent variations in each person’s associated microbial communities. Recent studies have begun to uncover how microbes interface with their host during exposure to drugs, dietary compounds, and environmental toxicants, with broader implications regarding the causes and consequences of biochemical individuality. Progress in this area will likely be an essential component of personalized medicine and might be accelerated through the implementation of experimental designs and theoretical principles honed through decades of work in the fields of toxicology and pharmacology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 3×
“…influence both energy intake and expenditure (Bäckhed et al., 2004; Greenblum et al., 2012; Koren et al., 2012; Le Chatelier et al., 2013; Ridaura et al., 2013; Turnbaugh et al., 2006; Vijay-Kumar et al., 2010) as well as diabetes risk (Karlsson et al., 2013; Qin et al., 2012; Wen et al., 2008).”
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 1×
“…studies promises to redefine what we think of ‘‘health’’ while also shedding new light on chronic diseases including metabolic syndrome (Ridaura et al., 2013), cardiovascular disease (Koeth et al., 2013), cancer (Kostic et al., 2013), and perhaps even behavioral disorders (Hsiao et al., 2013).”
Succession of microbial consortia in the developing infant gut microbiome
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · cited 1×
“Thus, these studies suggest that the human microbiota is dynamic and can exist in many configurations over a lifetime, consistent with studies of infants (Dominguez-Bello et al., 2010; Koenig et al., 2011), pregnant women (Koren et al., 2012), and the elderly (Claesson et al., 2012).”
Dethlefsen, L., & Relman, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000087107 · Cited by 2,421
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Kling Bäckhed, H., Gonzalez, A., Werner, J. J., Angenent, L. T., Knight, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.008 · Cited by 2,165 · cited 4×
“These emerging links might have been expected given evidence that the mammalian gut microbiome can influence both energy intake and expenditure (Bäckhed et al., 2004; Greenblum et al., 2012; Koren et al., 2012; Le Chatelier et al., 2013; Ridaura et al., 2013; Turnbaugh et al., 2006; Vijay-Kumar et al., 2010) as well a…”
InfluentialMetabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E., & Gewirtz, A. T. (2010) · Science · doi:10.1126/science.1179721 · Cited by 2,068
The Long-Term Stability of the Human Gut Microbiota
Faith, J. J., Guruge, J. L., Charbonneau, M., Subramanian, S., Seedorf, H., Goodman, A. L., Clemente, J. C., Knight, R., Heath, A. C., Leibel, R. L., et al. (2013) · Science · doi:10.1126/science.1237439 · Cited by 2,058
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., et al. (2008) · Nature · doi:10.1038/nature07336 · Cited by 1,921
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor
Smith, M. I., Yatsunenko, T., Manary, M. J., Trehan, I., Mkakosya, R., Cheng, J., Kau, A. L., Rich, S. S., Concannon, P., Mychaleckyj, J. C., et al. (2013) · Science · doi:10.1126/science.1229000 · Cited by 1,173 · cited 1×
“Considering recent evidence for geographical differences in microbial community structure (Smith et al., 2013; Yatsunenko et al., 2012), it seems likely that these studies vastly underestimate the range of configurations possible.”
Moving pictures of the human microbiome
Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D., Gonzalez, A., Stombaugh, J., Knights, D., Gajer, P., Ravel, J., Fierer, N., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-5-r50 · Cited by 1,138
Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota
Hehemann, J.-H., Correc, G., Barbeyron, T., Helbert, W., Czjzek, M., & Michel, G. (2010) · Nature · doi:10.1038/nature08937 · Cited by 1,117 · cited 1×
“The first clear example of this phenomenon was demonstrated for the marine bacterium Zobellia galactanivorans, which encodes enzymes capable of metabolizing the sulphated polysaccharide porphyran found in marine algae, but not in terrestrial plants (Hehemann et al., 2010).”
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism
Cabreiro, F., Au, C., Leung, K.-Y., Vergara-Irigaray, N., Cochemé, H. M., Noori, T., Weinkove, D., Schuster, E., Greene, N. D. E., & Gems, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.035 · Cited by 967 · cited 1×
“Elegant studies in the worm, Caenorhabditis elegans, demonstrated that metformin alters pathways for folate and methionine metabolism in their microbial food source (Escherichia coli), contributing to increased lifespan in the host organism (Cabreiro et al., 2013).”
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Ryan, K. K., Tremaroli, V., Clemmensen, C., Kovatcheva-Datchary, P., Myronovych, A., Karns, R., Wilson-Pérez, H. E., Sandoval, D. A., Kohli, R., Bäckhed, F., et al. (2014) · Nature · doi:10.1038/nature13135 · Cited by 931
Towards the human intestinal microbiota phylogenetic core
Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J., Ugarte, E., Muñoz‐Tamayo, R., Paslier, D. L. E., Nalin, R., et al. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01982.x · Cited by 927 · cited 1×
“It is possible to identify phylotypes that are found in >50% of samples, but they can vary dramatically in relative abundance (Huse et al., 2012; Tap et al., 2009; Turnbaugh et al., 2009, 2010).”
Genomic variation landscape of the human gut microbiome
Schloissnig, S., Arumugam, M., Sunagawa, S., Mitreva, M., Tap, J., Zhu, A., Waller, A., Mende, D. R., Kultima, J. R., Martin, J., et al. (2013) · Nature · doi:10.1038/nature11711 · Cited by 907
Dynamics and associations of microbial community types across the human body
Ding, T., & Schloss, P. D. (2014) · Nature · doi:10.1038/nature13178 · Cited by 885
Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes
Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., Takami, H., Morita, H., Sharma, V. K., Srivastava, T. P., et al. (2007) · DNA Research · doi:10.1093/dnares/dsm018 · Cited by 869 · cited 1×
“Metagenomic analyses have revealed that despite these differences in community structure, the relative abundance of many gene families and metabolic pathways is surprisingly stable (Consortium, 2012; Kurokawa et al., 2007; Turnbaugh et al., 2009).”
Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications · doi:10.1038/ncomms3384 · Cited by 705 · cited 8×
“FXR is a molecular target for the effects of vertical sleeve gastrectomy.”
InfluentialSelf-citationPredicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
Haiser, H. J., Gootenberg, D. B., Chatman, K., Sirasani, G., Balskus, E. P., & Turnbaugh, P. J. (2013) · Science · doi:10.1126/science.1235872 · Cited by 704 · cited 4×
“Recent studies have elucidated the inactivation of the cardiac drug digoxin by the gut Actinobacterium Eggerthella lenta (Haiser et al., 2013), a topic that has been discussed extensively elsewhere (Haiser et al., 2014).”
InfluentialSelf-citationThe gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618 · cited 2×
“Many of these reactions have been reproduced in vitro (Sousa et al., 2008), but no systematic surveys have been performed to see how many of the thousands of drugs and drug-like compounds are influenced.”
Flores, R., Shi, J., Fuhrman, B., Xu, X., Veenstra, T. D., Gail, M. H., Gajer, P., Ravel, J., & Goedert, J. J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-253 · Cited by 615 · cited 1×
“…lately due to their contributions to the dose-limiting side effects of multiple medications (LoGuidice et al., 2012; Saitta et al., 2014; Wallace et al., 2010), yet these same enzymes also contribute to the enterohepatic circulation of bile acids and the sex hormone estrogen (Flores et al., 2012).”
A Core Human Microbiome as Viewed through 16S rRNA Sequence Clusters
Huse, S. M., Ye, Y., Zhou, Y., & Fodor, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034242 · Cited by 572 · cited 2×
“…‘‘Human Microbiome Project’’ found that multiple body habitats exhibit marked variations in microbial community structure despite restricting their sampling to young adults from Missouri and Texas that were clinically screened for an absence of disease (Consortium, 2012; Huse et al., 2012).”
Koren, O., Knights, D., Gonzalez, A., Waldron, L., Segata, N., Knight, R., Huttenhower, C., & Ley, R. E. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002863 · Cited by 508 · cited 1×
“Comparative analyses of multiple body habitats revealed smooth abundance gradients of bacterial genera, with some signals of distinct states (also referred to as community types) in the gut and vagina (Ding and Schloss, 2014; Koren et al., 2013).”
Turnbaugh, P. J., Quince, C., Faith, J. J., McHardy, A. C., Yatsunenko, T., Niazi, F., Affourtit, J., Egholm, M., Henrissat, B., Knight, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002355107 · Cited by 478
Self-citationHehemann, J.-H., Kelly, A. G., Pudlo, N. A., Martens, E. C., & Boraston, A. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211002109 · Cited by 338 · cited 1×
“More recently, experimental support was provided to support the inferred porphyranase activity of this PUL in the gut microbiome (Hehemann et al., 2012).”
Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics
Carmody, R. N., & Turnbaugh, P. J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72335 · Cited by 268 · cited 1×
“…mediates the metabolic effects of drugs and environmental toxicants, as other recent reviews have provided a more in-depth view of the historic and current literature on drug and dietary bioactive metabolism (Carmody and Turnbaugh, 2014; Haiser and Turnbaugh, 2012, 2013; Sousa et al., 2008).”
Self-citationIntestinal Microbiota Regulate Xenobiotic Metabolism in the Liver
Björkholm, B., Bok, C. M., Lundin, A., Rafter, J., Hibberd, M. L., & Pettersson, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006958 · Cited by 249 · cited 1×
“…at least 44 drugs are directly metabolized by the gut microbiome (see Haiser and Turnbaugh, 2013, for a complete table), and a handful of others are thought to be indirectly influenced by the gut microbiome (Björkholm et al., 2009; Clayton et al., 2009; Iida et al., 2013; Viaud et al., 2013).”
Davey, K. J., Cotter, P. D., O'Sullivan, O., Crispie, F., Dinan, T. G., Cryan, J. F., & O'Mahony, S. M. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.83 · Cited by 236
LoGuidice, A., Wallace, B. D., Bendel, L., Redinbo, M. R., & Boelsterli, U. A. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191122 · Cited by 197
Haiser, H. J., Seim, K. L., Balskus, E. P., & Turnbaugh, P. J. (2014) · Gut Microbes · doi:10.4161/gmic.27915 · Cited by 197 · cited 2×
“Recent studies have elucidated the inactivation of the cardiac drug digoxin by the gut Actinobacterium Eggerthella lenta (Haiser et al., 2013), a topic that has been discussed extensively elsewhere (Haiser et al., 2014).”
Self-citationEnteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., Zeng, Z.-B., Wiest, M. M., Nguyen, U. T., Wojnoonski, K., Watkins, S. M., Trupp, M., & Krauss, R. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025482 · Cited by 193 · cited 1×
“…(Firm), glucose (Glc), gut microbiota (GM), 3-hydroxy-3methyl-glutaryl-CoA reductase (HMGCR), lowdensity lipoprotein (LDL), primary bile acids (1 BA), secondary bile acids (2 BA), and taurob-muricholic acid (TbMCA). in LDL cholesterol-lowering efficacy (Kaddurah-Daouk et al., 2011) (Figure 3A).”
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186 · cited 8×
“ductases have a similarly wide distribution among bacterial phyla (Haiser and Turnbaugh, 2013) and can act on therapeutic drugs (e.”
InfluentialSelf-citationSaitta, K. S., Zhang, C., Lee, K. K., Fujimoto, K., Redinbo, M. R., & Boelsterli, U. A. (2014) · Xenobiotica · doi:10.3109/00498254.2013.811314 · Cited by 165 · cited 2×
“…activity has increased lately due to their contributions to the dose-limiting side effects of multiple medications (LoGuidice et al., 2012; Saitta et al., 2014; Wallace et al., 2010), yet these same enzymes also contribute to the enterohepatic circulation of bile acids and the sex hormone…”
Cited by
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Environmental Endocrine-Disrupting Chemical Exposure: Role in Non-Communicable Diseases
Kumar, M., Sarma, D. K., Shubham, S., Kumawat, M., Verma, V., Prakash, A., & Tiwari, R. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.553850 · Cited by 391
An Intestinal Microbiota–Farnesoid X Receptor Axis Modulates Metabolic Disease
Gonzalez, F. J., Jiang, C., & Patterson, A. D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.057 · Cited by 372
Self-citationGut reactions: Breaking down xenobiotic–microbiome interactions
Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319
“…appear critical to both normal and perturbed regulation of metabolic activity, although not all aspects of these actions are mutually beneficial, and the rationale for either the host or the microbiome to have this capability is not always immediately obvious (Patterson and Turnbaugh, 2014).”
BackgroundGut Microbiota: The Conductor in the Orchestra of Immune–Neuroendocrine Communication
El Aidy, S., Dinan, T. G., & Cryan, J. F. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.03.002 · Cited by 215
Metadata
- Authors
- Patterson, A. D., & Turnbaugh, P. J.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 20
- Issue
- 5
- Pages
- 761-768
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2059903405
- Cited by
- 66
- References
- 37
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.